View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Vasculitis and Giant Cell Arteritis News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 09, 2022
1 min read
Save

ACR, Vasculitis Foundation guideline emphasizes prompt IVIG for Kawasaki disease

ACR, Vasculitis Foundation guideline emphasizes prompt IVIG for Kawasaki disease

The American College of Rheumatology and the Vasculitis Foundation have released new guidelines for Kawasaki disease, focusing on diagnostic issues, high-risk patients and convalescent patient management.

SPONSORED CONTENT
February 24, 2022
2 min read
Save

Nintedanib slows FVC decline in autoimmune-related interstitial lung disease

Nintedanib slows FVC decline in autoimmune-related interstitial lung disease

Nintedanib slows the rate of forced vital capacity decline in patients with fibrosing autoimmune disease-related interstitial lung disease, with adverse events manageable for most, according to data published in Arthritis & Rheumatology.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
February 23, 2022
2 min read
Save

Post-vaccine seronegativity predicts breakthrough COVID-19 in patients with AIRD

Post-vaccine seronegativity predicts breakthrough COVID-19 in patients with AIRD

Lack of antibody response following COVID-19 vaccination is the strongest predictor of breakthrough infection in patients with autoimmune rheumatic disease, according to data published in Annals of the Rheumatic Diseases.

SPONSORED CONTENT
February 21, 2022
2 min read
Save

Rhinovirus, RSV, varicella infections precede Kawasaki disease outbreaks by 1 to 3 months

Rhinovirus, RSV, varicella infections precede Kawasaki disease outbreaks by 1 to 3 months

Infections caused by rhinovirus, respiratory syncytial virus and varicella, precede Kawasaki disease outbreaks by 1 to 3 months in children and young adults in South Korea, according to data published in JAMA Network Open.

SPONSORED CONTENT
January 20, 2022
52 min listen
Save

Leadership, Research and Patient Care with Kristin Highland, MS, MD

Leadership, Research and Patient Care with Kristin Highland, MS, MD

Kristin B. Highland, MD, does it all and makes it look easy. In this episode, we discuss how to follow your dreams, balance your life and define success on your own terms.

SPONSORED CONTENT
January 14, 2022
8 min read
Save

Older woman develops acute, painless, monocular vision loss

Older woman develops acute, painless, monocular vision loss

An 88-year-old woman developed an acute onset of painless, monocular vision loss in the right eye.

SPONSORED CONTENT
January 12, 2022
2 min read
Save

Flares, breakthroughs rare after COVID-19 vaccination in inflammatory rheumatic disease

Flares, breakthroughs rare after COVID-19 vaccination in inflammatory rheumatic disease

Just 0.7% of fully vaccinated patients with inflammatory rheumatic and musculoskeletal disease experience a breakthrough COVID-19 infection, while only 4.4% demonstrate disease flare reactions, according to data.

SPONSORED CONTENT
December 30, 2021
2 min read
Save

DMARD interruptions rose 80% in early 2021 among autoimmune rheumatic patients

DMARD interruptions rose 80% in early 2021 among autoimmune rheumatic patients

DMARD interruptions in patients with autoimmune rheumatic diseases increased more than 80% between December 2020 and May 2021, leading to higher rates of self-reported flares, according to data published in Arthritis Care & Research.

SPONSORED CONTENT
December 07, 2021
2 min read
Save

Tocilizumab delays flare, reduces glucocorticoid dose in new-onset giant cell arteritis

Tocilizumab delays flare, reduces glucocorticoid dose in new-onset giant cell arteritis

Weekly tocilizumab delays initial flare and reduces glucocorticoid exposure in patients with relapsing and new-onset giant cell arteritis, according to data published in Rheumatology.

SPONSORED CONTENT
December 06, 2021
2 min read
Save

Rare autoimmune rheumatic diseases more than double risk for COVID-19 death

Rare autoimmune rheumatic diseases more than double risk for COVID-19 death

Patients with rare autoimmune rheumatic diseases have a 54% increased risk for COVID-19 infection, and more than twice the risk for COVID-19 death, versus the general population, according to data published in Rheumatology.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails